Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - glucosum anhydricum, triglycerida, aminoacida, carbohydrata, materia crassa, natrium, kalium, magnesium, calcium, phosphas, zincum, sulfas, chloridum, acetas, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum, calcii chloridum dihydricum, natrii glycerophosphas, magnesii sulfas anhydricus, kalii chloridum, natrii acetas anhydricus, zinci sulfas anhydricus - infusionsemulsion - i) glucoselösung: glucosum anhydricum 125 g ut glucosum monohydricum, aqua ad iniectabilia q.s. ad solutionem pro 298 ml. ii) aminosäurelösung mit elektrolyten: alaninum 7 g, argininum 6 g, glycinum 5.5 g, histidinum 1.5 g, isoleucinum 2.5 g, leucinum 3.7 g, lysinum anhydricum 3.3 g ut lysini acetas, methioninum 2.15 g, phenylalaninum 2.55 g, prolinum 5.6 g, serinum 3.25 g, taurinum 0.5 g, threoninum 2.2 g, tryptophanum 1 g, tyrosinum 0.2 g, valinum 3.1 g, calcii chloridum dihydricum 370 mg, natrii glycerophosphas 2.09 g, magnesii sulfas anhydricus 600 mg ut magnesii sulfas heptahydricus, kalii chloridum 2.24 g, natrii acetas anhydricus 1.7 g ut natrii acetas trihydricus, zinci sulfas anhydricus 6.45 mg ut zinci sulfas heptahydricum, aqua ad iniectabilia q.s. ad solutionem pro 500 ml. iii) fettemulsion: triglycerida 37.6 g, phospholipida purificata ex ovo, glycerolum 4.136 g, aqua ad iniectabilia q.s. ad emulsionem pro 188 ml. i) et ii) et iii) corresp.: aminoacida 51 g/l, carbohydrata 127 g/l, materia crassa - parenterale ernährung - synthetika human

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - glucosum monohydricum, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum, calcii chloridum dihydricum, natrii glycerophosphas, magnesii sulfas heptahydricus, kalii chloridum, natrii acetas trihydricus, zinci sulfas heptahydricum, triglycerida saturata media, aminoacida, materia crassa, carbohydrata, natrium, kalium, magnesium, calcium, phosphas, zincum, sulfas, chloridum - infusionsemulsion - i) glucose-lösung 13%: glucosum monohydricum 71 g, aqua ad iniectabilia q.s. ad solutionem pro 544 ml. ii) aminosäurenlösung 10 % mit elektrolyten: alaninum 4.4 g, argininum 3.8 g, glycinum 3.5 g, histidinum 930 mg, isoleucinum 1.6 g, leucinum 2.3 g, lysinum anhydricum 2.1 g ut lysini acetas, methioninum 1.3 g, phenylalaninum 1.6 g, prolinum 3.5 g, serinum 2.1 g, taurinum 320 mg, threoninum 1.4 g, tryptophanum 630 mg, tyrosinum 120 mg, valinum 2 g, calcii chloridum dihydricum 180 mg, natrii glycerophosphas 1.3 g, magnesii sulfas heptahydricus 380 mg, kalii chloridum 1.4 g, natrii acetas trihydricus 1.1 g, zinci sulfas heptahydricum 4 mg, acidum aceticum ad ph, aqua ad iniectabilia q.s. ad solutionem pro 315 ml. iii) fettemulsion 20%: triglycerida saturata media 28 g, phospholipida purificata ex ovo, glycerolum, natrii hydroxidum ad ph, aqua ad iniectabilia q.s. ad emulsionem pro 141 ml. i) et ii) et iii) corresp.: aminoacida 31.5 g/l, materia crassa 28 g/l, carbohydrata 71 g/l, mineralia: natrium 25 mmol/l, k - periphervenöse parenterale ernährung - synthetika human

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - glucosum anhydricum, triglycerida saturata media, olivae oleum raffinatum, piscis oleum, aminoacida, nitrogenia, carbohydrata, materia crassa, acetas, phosphas, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum - infusionsemulsion 1970 ml - i) glucoselösung 42 %: glucosum anhydricum 250 g ut glucosum monohydricum, aqua ad iniectabilia q.s. ad solutionem pro 595 ml. ii) aminosäurenlösung: alaninum 14 g, argininum 12 g, glycinum 11 g, histidinum 3 g, isoleucinum 5 g, leucinum 7.4 g, lysinum anhydricum 6.6 g ut lysini acetas, methioninum 4.3 g, phenylalaninum 5.1 g, prolinum 11.2 g, serinum 6.5 g, taurinum 1 g, threoninum 4.4 g, tryptophanum 2 g, tyrosinum 400 mg, valinum 6.2 g, aqua ad iniectabilia q.s. ad solutionem pro 1000 ml. iii) fettemulsion: sojae oleum raffinatum, triglycerida saturata media 22.5 g, olivae oleum raffinatum 18.8 g, piscis oleum 11.3 g, int-rac-alfa-tocopherolum, phospholipida purificata ex ovo, glycerolum, natrii oleas, aqua ad iniectabilia q.s. ad emulsionem pro 375 ml. . i) et ii) et iii) corresp.: aminoacida 100 g, nitrogenia 16 g, carbohydrata 250 g, materia crassa 75 g, acetas 147 mmol, phosphas 5.6 mmol, in emulsione recenter mixta 1970 ml. corresp. 9200 kj pro 1970 ml. - parenterale ernährung für erwachsene - synthetika

Italië - Italiaans - Ministero della Salute

tekscan inc. - strumentazione per medicina generale non altrimenti classificata

Italië - Italiaans - Ministero della Salute

vita al top srl -

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - albuminum humanum - soluzione per infusione - albuminum humanum 200 g, natrii caprylas, n-acetyltryptophanum, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 l corresp. natrium 3.33 g. - recupero e conservazione del kreislaufvolumens, se un volumendefizit è stata identificata, e l'uso di un colloide è visualizzata - emoderivati

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

octapharma ag - antithrombinum iii humanum - polvere e solvente per soluzione per infusione - praeparatio cryodesiccata: antithrombinum iii humanum 500 u.i. corresp. antithrombinum iii humanum 70-100 mg, albuminum humanum, n-acetyltryptophanum, acidum caprylicum, natrii chloridum corresp. natrium 35 mg, pro vitro. solvens: aqua ad iniectabile 10 ml. - behandlung von patienten mit hereditärem oder erworbenem antithrombin iii-mangel - emoderivati

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

dudler pharma sàrl - albuminum humanum - soluzione versare perfusione - albuminum humanum 200 g, natrii chloridum, natrii caprylas, n-acetyltryptophanum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml, natrium 123.5 - 136.5 mmol. - rétablissement et maintien du volume sanguin lorsqu’une hypovolémie a été observée et que l’administration d’un colloïde est recommandée. - emoderivati

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

dudler pharma sàrl - albuminum humanum - soluzione versare perfusione - albuminum humanum 250 g, natrii chloridum, natrii caprylas, n-acetyltryptophanum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml, natrium 123.5 - 136.5 mmol. - rétablissement et maintien du volume sanguin lorsqu’une hypovolémie a été observée et que l’administration d’un colloïde est recommandée. - emoderivati

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

octapharma ag - albuminum humanum - soluzione per infusione - albuminum humanum 50 g, natrii chloridum corresp. natrium 144 - 160 mmol, n-acetyltryptophanum, acidum caprylicum, aqua ad iniectabile q.s. ad solutionem pro 1 l. - ripristino e mantenimento del volume ematico circolante in caso di accertata volumenmangel, quando l'uso di un colloide è visualizzato. - emoderivati